| (S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate |
(S)-(+)-2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-基)乙酸叔丁酯 |
1268524-70-4 |
| MCB-613 |
4-乙基-2,6-双(吡啶-3-基亚甲基)环己酮 |
1162656-22-5 |
| ethyl 4-(((2R,3R,4S,5R,6S)-4,5-bis(benzo[d][1,3]dioxol-5-ylcarbamoyloxy)-2-(hydroxymethyl)-6-methoxy-tetrahydro-2H-pyran-3-yloxy)carbonyl)benzoate |
BRD7552 |
1137359-47-7 |
| RSL3 |
CS-2409 |
1219810-16-8 |
| AZD2461 |
4-[4-氟-3-[(4-甲氧基哌啶-1-基)羰基]苄基]酞嗪-1(2H)-酮 |
1174043-16-3 |
| b-AP15 |
b-AP15 |
1009817-63-3 |
| PF 04418948 |
PF04418948 |
1078166-57-0 |
| IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
PQ 401 |
196868-63-0 |
| DBeQ |
DBEQ |
177355-84-9 |
| L-OrnithinaMide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aMinocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]Methyl]phenyl]- |
马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂 |
159857-81-5 |
| COMPOUND 401 |
COMPOUND 401 |
168425-64-7 |
| SB 202190 |
4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑 |
152121-30-7 |
| VUF 10166 |
VUF 10166 |
155584-74-0 |
| MDL-29951 |
MDL-29951 |
130798-51-5 |
| CP21R7(CP21) |
GSK-3Β抑制剂(CP21R7) |
125314-13-8 |
| AMG-706 |
二磷酸莫替沙尼 |
857876-30-3 |
| 5-((7-Cl-1H-indol-3-yl)Methyl)-3-MethyliMidazolidine-2,4-dione) |
5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮 |
852391-15-2 |
| 7ACC-2 |
7ACC-2 |
1472624-85-3 |
| PU-WS13 |
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 |
1454619-14-7 |
QQ
微信
